The market is segmented based on , By Indication (CF, DMD, LSD, PNH), Disease Type ('Alzheimer's Disease, Cancer, Cystic Fibrosis, Sickle Cell Anaemia, DMD, Thalassemia, 'Huntington's Disease, Rare Diseases, Others) – Industry Trends and Forecast to 2030.
.
The Global Genetic Disorders Market size was valued at USD 14954.67 USD Million in 2022.
The Global Genetic Disorders Market is projected to grow at a CAGR of 12.2% during the forecast period of 2023 to 2030.
The major players operating in the market include Amicus TherapeuticsInc. ,Alexion PharmaceuticalsInc. ,Sanofi ,Takeda Pharmaceutical Company Limited ,Vertex Pharmaceuticals Incorporated U.S),F. Hoffmann-La Roche Ltd ,Abbott ,Amgen Inc. ,ELITechGroup ,GW Pharmaceuticals plc. ,Pfizer Inc. ,PerkinElmer Inc ,AutoGenomics ,Bio-Rad LaboratoriesInc. ,BioMarin ,Sarepta Therapeutics .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa..
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.